Clean Science & Technology Ltd Q4 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Published 24 May 2026 | Chemicals & Petrochemicals | Market Cap: ₹8.2K Cr
HALS sales have shown strong growth, increasing from ~350-360 tonnes per quarter eight quarters ago to over 1,000 tonnes per quarter currently, with momentum expected to build further. HALS business shows strong momentum with sales increasing from ~350-360 tonnes per quarter (8 quarters ago) to over 1,000 tonnes per quarter currently, with expectations to continue building volumes and improving margins through higher-grade products and backward integration.
From Clean Science & Technology Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Price
₹826
Market Cap
₹8.2K Cr
P/E Ratio
35.1
How does Clean Science & Technology Ltd rank in Chemicals & Petrochemicals?
Compare Clean Science & Technology Ltd against every Chemicals & Petrochemicals company this quarter on revenue, margins and earnings-call signals.
Clean Science & Technology Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹249 Cr, net profit ₹58 Cr.
Full financials →📊 Revenue & Sales Performance
- →HALS sales have shown strong growth, increasing from ~350-360 tonnes per quarter eight quarters ago to over 1,000 tonnes per quarter currently, with momentum expected to build further.
- →Higher grades of HALS are contributing to better revenue and margins, indicating improved product mix.
- →No specific price hike guidance for FY27 due to evolving market conditions, but inflationary environment is favorable.
- →Backward integration initiatives (e.g., conversion of DHDT plant) aim to reduce import dependence and improve margins, though no utilization targets have been disclosed.
- →Stand-alone business volumes grew sequentially by about 8%, mostly volume-led growth.
- →New capex of INR 80-100 crores planned in FY27, likely in the latter half, to support growth initiatives.
- →Overall, FY27 growth is expected with volume ramp-up, improved efficiencies, and favorable product mix, though macro uncertainties make precise forecasts challenging.
📈 Profitability & Margins
- →HALS business shows strong momentum with sales increasing from ~350-360 tonnes per quarter (8 quarters ago) to over 1,000 tonnes per quarter currently, with expectations to continue building volumes and improving margins through higher-grade products and backward integration.
- →FY27 capex is planned between INR 80 crores to 100 crores, focusing on debottlenecking and backward integration, expected to support margin improvement and volume ramp-up.
- →Hydroquinone/Catechol plant is under initial stabilization; volumes and yields are expected to improve over 1-2 quarters, contributing positively to earnings.
- →Pricing environment is inflationary; while price hikes are uncertain, the company benefits from inflationary conditions improving margins.
- →Export share in HALS has increased to 50% from 20%, improving revenue and margin profiles.
- →Due to geopolitical and global macro uncertainties (crude oil, China supply), FY27 outlook is cautious and dependent on external factors.
- →Overall, volume-led revenue growth and margin expansion expected, but management foresees a "tricky" year due to external variables.
🏗️ Capital Expenditure Plans
💰 Fundraising & Capital Structure
- →The company has taken an enabling resolution to invest up to INR 200 crores in Clean Fino-Chem for projects including possible greenfield capex; these are in the initial stages with no specific capex timing detailed yet.
- →For FY27, the capex budget is projected between INR 80 crores to INR 100 crores.
- →No explicit mention was made about raising new debt or equity to fund these expansions or capex during the call.
- →The capital infusion in the subsidiary so far stands at approximately INR 200 crores, with total subsidiary investment at INR 750 crores as of the call.
- →Discussions suggest internal accruals and existing resources may be used, with no direct announcement of upcoming fundraising through debt or equity noted in the transcript.
📋 Order Book & Pipeline
Key Metrics
Frequently Asked Questions
What were Clean Science & Technology Ltd Q4 FY26 results?
HALS sales have shown strong growth, increasing from ~350-360 tonnes per quarter eight quarters ago to over 1,000 tonnes per quarter currently, with momentum expected to build further. HALS business shows strong momentum with sales increasing from ~350-360 tonnes per quarter (8 quarters ago) to over 1,000 tonnes per quarter currently, with expectations to continue building volumes and improving margins through higher-grade products and backward integration.
What is Clean Science & Technology Ltd share price analysis?
Clean Science & Technology Ltd currently shows a neutral. The stock trades at a P/E of 35.1 with a market cap of ₹8,173 Cr. Investors should review the full earnings analysis for detailed insights.
Is Clean Science & Technology Ltd planning capital expenditure?
Capex budget for FY27 is expected to be in the range of INR 80 crores to INR 100 crores (Page 16).
Keep Clean Science & Technology Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.